February 16, 2009: NanoVentures Australia Ltd. will take over where NanoVic left off in helping to commercialize nanotechnology in Australia.
The new group was formed after NanoVic’s six-year nanotech investment and commercialization mission for the Victorian government was completed.
Now, NVA’s primary mandate is to commercialize the technologies developed under NanoVic’s agreements in ways that were not feasible under NanoVic’s corporate structure.
NVA has a small grant from the Victorian government to enable the transition, and has recruited the NanoVic team. NVA will not invest in research projects, but as an independent commercial entity, NVA can be a partner in applications to state and commonwealth funding pools, such as ARC, NH&MRC and Climate Ready.
The new NVA Board is comprised of experienced industry and investment executives, including Tina McMeckan (Circadian), Shirley Lanning (Watermark), and Greg Smith (SciVentures).
The primary portfolios within NVA include advanced nanomaterials, water and environmental technologies, therapeutic delivery systems and medical diagnostics.